[Polarisqb in PR Newswire] POLARISqb and PhoreMost announce a multi-target collaboration to investigate next-generation cancer therapies

Source Node: 1883336

Polaris Quantum Biotech (POLARISqb), a NC-based quantum computing drug design company, and PhoreMost Limited, a UK-based biopharmaceutical company dedicated to developing drugs against intractable disease targets, today announced a collaboration to study oncology targets currently considered undruggable. 

Read more here.

Source: https://blog.ourcrowd.com/polarisqb-and-phoremost-announce-a-multi-target-collaboration-to-investigate-next-generation-cancer-therapies/

Time Stamp:

More from OurCrowd Blog